About us
- Simplicity
- Versatility
- Performance
Cost-Efficient innovation in organic chemistry
By offering automated equipment, encompassing both continuous flow and batch reactors, we are committed to providing solutions accessible to all, significantly accelerating the development of new molecules. These cutting-edge technologies are designed to be fully adaptable to industrial demands, propelling research and production into the future.
Intuitive, easy to maintain, modular, and robust solution
At Synlock, we have set a clear goal: to develop a versatile automated system capable of performing a wide range of organic chemistry reactions.
We understand the challenges laboratories face: software complexity, wasted time programming chemical recipes, and the need for flexible yet affordable equipment. That's why we strive to create an automated synthesizer that eliminates these obstacles.
Why Cheminizer?
- Cheminizer is designed for chemists, by chemists. We've focused on flexibility and ease of use, ensuring our technology remains accessible and easy to maintain for most chemical laboratories.
Versatile Synthetizer
It offers you the freedom to perform a multitude of reactions without worrying about programming constraints. Stay tuned as we unlock an even wider range of chemical syntheses.Trustable
Cheminizer offers exceptional robustness and reliability, consistently delivering repeatable and reproducible results. This facilitates the seamless transfer of protocols between different units, ensuring unvarying performance.
Synlock was born from the collaboration between researchers and engineers driven by a shared ambition: to bring breakthrough automation to chemistry.
Our roots trace back to Optimized Radiochemical Application, a company specialized in designing and producing radiosynthesizers. After more than a decade of successful partnerships with major pharmaceutical companies and academic institutions, several key questions kept coming back:
Why does automation arrive so late in drug development? And how could we make chemical reactions more efficient and scalable?
This challenge led to our first standalone thin-film rotary reactor prototype, which quickly proved its exceptional performance in radioactive applications — and revealed a much broader potential for chemistry as a whole.
In 2022, we founded Synlock to turn this vision into reality and created the Cheminizer — an automated solution designed to transform the way chemists perform and accelerate their reactions.
Our Team

Vincent Tadino
- PhD in Organic Chemistry . University of Liège, Belgium
- PostDoc research in Organic Chemistry . ISMRA of Caen, France
Vincent served as radiochemist for 7 years in different companies active in PET radiopharmaceutical equipment and production, both in Europe and the USA. Then, he founded Optimized Radiopharmaceutical company (ORA) in 2006 and still serve as president. ORA has sold more than 600 Neptis synthesizers worldwide for the production of radiopharmaceuticals.
With the creation of Cheminizer, he wants to bring more than 25 years of experience acquired in radiochemistry automation, GMP and software development under the GAMP 5 standard to the world of organic chemistry.

Guillaume Villeret
- Master’s in Chemistry and Bachelor in Science in Computer Science . University of Liège, Belgium
After starting as a radiochemist at ORA in 2008, and then participating at the creation of the Neptis synthesizers (2009/2010), Guillaume was appointed Technical Director in 2011. In this position, Guillaume is responsible of overseeing the engineering team assigned to install and maintain radio-synthesizer machines.
He is still performing installations and maintenances himself when needed, keeping him close to the field. He is also leading the after sales department, and he is making sure customers get answers and solutions.

Nicolas Maindron
- PhD in Organic Chemistry. University of Rouen, France
Nicolas earned a PhD degree in Organic Chemistry from the University of Rouen, France. Before joining Synlock, he worked in the radiopharmaceuticals R&D department of a clinical research company in the US. He gained also experience in automation at ORA which is a Belgium-based company specialized in the manufacturing of automated devices for the synthesis of radioactive chemical where he contributed to the development of new radiosynthetizers and radiosynthesis.

Yoann Joyard
- PhD in Organic Chemistry. INSA Rouen, France
Yoann holds a PhD in Organic Chemistry from INSA Rouen. He has worked on the development of fluorinated tracers and novel fluorination methodologies. He carried out a postdoctoral research at King’s College London in the School of Biomedical Engineering and Imaging Sciences, and spent two years as a research engineer in continuous-flow and batch process development.
From 2017 to 2025, he contributed to the design of a new generation of radiosynthesizers at ORA (Optimized Radiochemical Application). Overall, he brings 12 years of experience in chemical development, automation, and digitalization.

Geoffroy Kaisin
- PhD in Organic Chemistry. University of Liège, Belgium
Geoffroy earned his PhD at the University of Liège, developing synthetic methods for monomers used in radiolabelled nanoparticles. He was an early employee at Advanced Nuclear Medicine Ingredients (ANMI), contributing to a patented cold kit formulation for a radiotracer.
After ANMI’s acquisition by Telix Pharmaceuticals in 2018, his research focused on novel radiometal automated labelling strategies for biomolecules.